foxo4-dri human trial senolytic The costs and benefits of senotherapeutics for health Molecular modelling of the FOXO4-TP53

R 3 is H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, optionally substituted C 3 -C 6 cycloalkyl, optionally substituted C 2 -C 7 heterocycloalkyl, optionally substituted C 6 -C 10 aryl, optionally substituted C 3 -C 9 heteroaryl, OR 6 , NR 5 R 6 , C(O)R 7 , -0O 2 R 6 , C(O)NR 5 R 6 , N(R 5 )C(O)R 7 , N(R 5 )CO 2 R 7 , NHS(O) 2 R 7 , S(O) 2 NR 5 R 6 , or R 2 and R 3 together form an optionally substituted C 2 -C 7 heterocycloalkyl ring

The mnage trois of autophagy, lipid droplets and liver disease

Hassle-free setup with an active adapter that features plug-and-play installation To ensure compatibility with any DisplayPort output, the DP adapter offers active conversion

These include diffusion-controlled release, solvent-controlled release (e.g., osmosis- and swelling-controlled release), degradation-controlled release, and stimuli-responsive release (e.g., pH, ionic strength, temperature, and electric or magnetic fields) (Lee and Yeo, 2015)

4 , e371 (2017)

6b and c)